Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis

NCT03445845 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Axial Spondyloarthritis

Interventions

DRUG: Secukinumab
DRUG: TNF blocker
BIOLOGICAL: blood specimen

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Collaborators

[object Object]